164 related articles for article (PubMed ID: 25602791)
1. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials.
Mills AM; Paquette C; Castle PE; Stoler MH
Am J Surg Pathol; 2015 May; 39(5):611-7. PubMed ID: 25602791
[TBL] [Abstract][Full Text] [Related]
2. CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.
Mills AM; Paquette C; Terzic T; Castle PE; Stoler MH
Am J Surg Pathol; 2017 Feb; 41(2):143-152. PubMed ID: 27680604
[TBL] [Abstract][Full Text] [Related]
3. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
4. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
[TBL] [Abstract][Full Text] [Related]
6. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
7. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
Pacchiarotti A; Ferrari F; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
Int J Cancer; 2014 Feb; 134(4):897-904. PubMed ID: 23913416
[TBL] [Abstract][Full Text] [Related]
9. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.
Liu C; Du H; Wang C; Belinson JL; Yang B; Zhang W; Tang J; Wu R
Int J Gynecol Pathol; 2017 May; 36(3):281-288. PubMed ID: 28277314
[TBL] [Abstract][Full Text] [Related]
10. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract][Full Text] [Related]
11. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
12. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
[TBL] [Abstract][Full Text] [Related]
13. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
Jackson JA; Kapur U; Erşahin Ç
Int J Surg Pathol; 2012 Apr; 20(2):146-53. PubMed ID: 22104735
[TBL] [Abstract][Full Text] [Related]
14. A population of 1136 HPV DNA-HR positive women: expression of p16(INK4a)/Ki67 Dual-Stain Cytology and cytological diagnosis. Histological correlations and cytological follow up.
Rossi P; Borghi L; Ferro R; Mencarelli R
Pathologica; 2015; 107(3-4):185-91. PubMed ID: 26946874
[TBL] [Abstract][Full Text] [Related]
15. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
[TBL] [Abstract][Full Text] [Related]
16. Progression of Precancerous Cervical Lesion Predicted by p16 Protein Immunohistochemistry in Rajavithi Hospital.
Charoonwatana T; Boonlikit S; Yanaranop M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1809-1815. PubMed ID: 31244304
[TBL] [Abstract][Full Text] [Related]
17. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.
Zhong P; Li J; Gu Y; Liu Y; Wang A; Sun Y; Lu L
Int J Clin Exp Pathol; 2015; 8(3):2979-86. PubMed ID: 26045807
[TBL] [Abstract][Full Text] [Related]
18. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
19. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations.
Singh C; Manivel JC; Truskinovsky AM; Savik K; Amirouche S; Holler J; Thyagarajan B; Gulbahce HE; Pambuccian SE
Arch Pathol Lab Med; 2014 Jan; 138(1):76-87. PubMed ID: 24377814
[TBL] [Abstract][Full Text] [Related]
20. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
